« Return To News

FDA Move Opens Funding, Market Assistance for Lung Therapeutics

Lung Therapeutics, Inc. (LTI), an Austin-based pharmaceutical startup, will get special considerations from the U.S. Food and Drug Administration to help it develop an injectable drug treatment for a common complication of pneumonia.

by Chad Swiatecki, Staff Writer
AUSTIN BUSINESS JOURNAL

READ FULL ARTICLE